Iatrogenic Effect Clinical Trial
Official title:
Effect of the Use of a Therapeutic Conciliation Document at the Outlet of Hospital, on the Emergency Use of Hospital Care in Patient Aged Over 75 Years Old.
The drug iatrogenesis represents an important public health problem. In the Iatromed project, we want to to assess a specific therapeutic drug conciliation sheet (TDC). This multicenter observational study is focus on 750 patients aged over 75 year old with polymedication. The main objective will be to determine if the use of the TDC, at the discharge of hospital, allows to reduce the number of use in emergency care within the two month after their hospital discharge
The drug iatrogenesis represents an important public health problem with 5-10% of the grounds
of hospitalization after age 65, and more than 20% after 80 years. Based on this observation,
the health authority has proposed in 2011 the realization of therapeutic drug conciliation
particularly in the elderly with multiple pathologies and multiple drugs. Taking into account
the central role of the family practitioner in prescriptions, and the importance of
coordination information such as output of hospitalization (vector of many malfunctions), we
have achieved a therapeutic drug conciliation sheet (TDC) based primarily on the information
needs by family practitioner after hospitalization of their patients. The issue of this study
is to assess the interest for the use of a such TDC on the decrease in the rate of
rehospitalization in the target population.
To do this, we are proposing a multicenter observational study. Randomization would be across
the centres. The study would focus on 750 patients more of 75 with polymedication. The
follow-up will last 6 months.
The main objective will be to determine if the use of the TDC, at the discharge of hospital,
allows to reduce the number of use in emergency care within the two month after their
hospital discharge. The first secondary objective will be identical to the main objective but
rated at 6 months and the second secondary objective will be to assess the impact of the use
of the TDC on overall mortality at 6 months.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05045235 -
Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk
|
||
| Active, not recruiting |
NCT05179642 -
OPTIM-EHPAD Optimization of Drug Prescription for Each Resident Entering in Nursing Home (EHPAD).
|
||
| Active, not recruiting |
NCT04923750 -
Detection of Acute Renal Failure Using Hospital Coding Data
|
||
| Not yet recruiting |
NCT06145126 -
Effects of Glucocortioids in Human Skeletal Muscle, Adipose Tissue and Skin
|
N/A |